ACT Genomics at MEDICA 2026 | Advancing Precision Oncology Worldwide

ACT Genomics is pleased to announce our participation in MEDICA 2026, the premier international trade fair for medical technology and healthcare innovation.

As precision oncology reshapes cancer care, ACT Genomics continues to push boundaries with our robust Next-Generation Sequencing (NGS) and proprietary bioinformatics capabilities. We empower clinicians, biopharma partners, and researchers by translating complex genomic profiles into actionable clinical insights.

We warmly invite global pharmaceutical partners, clinical experts, and industry distributors to meet our team in Düsseldorf. Discover how our comprehensive genomic profiling solutions can drive research, optimize therapy selection, and advance personalized medicine together.

Event Details

• ‍Date: November 16–19, 2026‍
• Venue: Messe Düsseldorf, Germany | Taipei Pavilion (Organized by the Department of Economic Development, Taipei City Government)‍
• Location: Hall 16, Booth C23-7

More information: https://www.medica-tradefair.com/vis/v1/en/exhprofiles/VTUMjphaRdSjJzKUsNV2tw?ticket=43897496947418